Eventide Asset Management, LLC Roivant Sciences Ltd. Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$8.38 - $11.58 $4.58 Million - $6.33 Million
-546,362 Reduced 32.32%
1,143,938 $12.8 Million
Q1 2022

May 16, 2022
BUY
$4.74 - $9.91 $4.69 Million - $9.81 Million
990,300 Added 141.47%
1,690,300 $8.18 Million
Q4 2021

Feb 14, 2022
BUY
$5.86 - $13.52 $4.1 Million - $9.46 Million
700,000 New
700,000 $6.7 Million

Others Institutions Holding ROIV

# of Institutions
315
Shares Held
507M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.85B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email